Rankings
▼
Calendar
CMPX Q2 2018 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CMPX
Compass Therapeutics, Inc.
$764M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
$0
Net Income
$0
EPS (Diluted)
$0.00
Cash Flow
Operating Cash Flow
-$7,894
Free Cash Flow
-$7,894
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$7,231
Total Liabilities
$50,257
Stockholders' Equity
-$43,026
Cash & Equivalents
$7,231
← FY 2018
All Quarters
Q1 2019 →